Tissue Factor Released from Leukemic Cells

Summary

Using clotting assay and radioimmunoassay (RIA), tissue factor activity (TFA) and TF related antigen (TFR:AG) were determined in an extracellular culture medium of HL-60 cells. After 12 h incubation, TFA and TFR:AG in the medium with endotoxin (EDX: 1 μg/ml) reached maximums which were 1.8 and 2.1 times greater than those in the medium without EDX, respectively. In the leukemic cells of 10 patients with acute nonlymphoid leukemia (ANLL), TFR:AG showed a significant correlation with TFA (p <0.01). On day 1 of the induction chemotherapy, TFR:AG in the 7 patients with DIC significantly increased to 288.9 ± 153.1 ng/ml (p <0.01), whereas no increase in TFR: AG was recognized in the 3 patients without DIC. These results suggest that TF may be released from leukemic cells into the culture medium or blood stream, and that this may correlate with the development of DIC.

• References

• 1 Gralnick HR, Sultan C. Acute promyelocytic leukemia: Haemor-rhagic manifestation and morpologic criteria. Br J Haematol 1975; 29: 373-376
• 2 Henderson ES. Acute leukemia general considerations. In: Hematology Williams WJ, Beutler E, Erslev AJ, Lichtman MA. (eds). McGraw-Hill; New York: 1983: 221-239
• 3 Guarini A, Gugliotta L, Timoncini C, Chetti L, Catani L, Russo D, Tura S. Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia. Scand J Haematol 1985; 34: 152-156
• 4 Gouault-Heilman M, Chardon E, Sultan C, Josso F. The procoagulant factor of leukemic promyelocytes: Demonstration of immunologic cross reactivity with human brain tissue factor. Br J Haematol 1975; 30: 151-158
• 5 Andoh K, Kubota T, Takada M, Tanaka H, Kobayashi N, Maekawa T. Tissue factor activity in leukemia cells. Special reference to disseminated intravascular coagulation. Cancer 1987; 59: 748-754
• 1 Gonmori H, Maekawa T, Kobayashi N, Tanaka H, Takada M, Andoh K. The role of tissue thromboplastin in the development of DIC accompanying neoplastic diseases. In: Disseminated intravascular Coagulation Abe T, Ymanaka M. (eds). University of Tokyo press; Tokyo: 1983: 23-39
• 7 Maekawa T, Gonmori H. Tissue thromboplastin in leukocytes from various leukemia and its localization by immunoperoxidase staining method (Abstr). Thromb Diath Haemorrh 1977; 38: 151
• 8 Tanaka H, Narahara N, Kurabayashi H, Sadakata H, Andoh K, Uchiyama T, Kobayashi N, Maekawa T. Studies of leukemic cell tissue factor. Thromb Res 1989; 53: 535-549
• 9 Andoh K, Kubota T, Kobayashi N, Maekawa T. Radioimmunoassay of human tissue factor. Thromb Res 1986; 43: 275-286
• 10 Bona R, Lee E, Rickies F. Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles. Thromb Res 1987; 48: 487-450
• 11 Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA G, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. Br J Haematol 1976; 33: 451-458
• 12 Ohno R, Hirano M, Imai K, Koie K, Kamiya T, Nishimaki H, Ishiguro J, Uetani T, Sako F, Imanura K. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) coombination chemotherapy for acute myelogenous leukemia in adults. Cancer 1975; 36: 1945-1949
• 13 Kobayashi N, Maekawa T, Takada M, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 patients collected by the Research Committee on DIC in Japan. In: Disseminated Intravascular Coagulation Abe T, Yamanaka M. (eds). University of Tokyo Press; Tokyo: 1983: 265-275
• 14 Gonmori H, Takeda Y. Properties of canine tissue thromboplastins from brain, lung, arteries and veins. Am J Physiol 1975; 229: 619-626
• 15 Nemerson Y. The phospholipid requirement of tissue factor in blood coagulation. J Clin Invest 1968; 47: 72-80
• 16 Bolton AE, Hunter WM. The labelling of proteins to high specific radioactivities by conjugation to a ¹²⁵I-containing acylating agent. Biochem J 1973; 133: 529-538
• 17 Hales CN, Randle PJ. Immunoassay of insulin with insulin-antibody precipitate. Biochem J 1963; 88: 137-146
• 18 Maynard JR, Heckman CA, Pitlick FA, Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest 1975; 55: 814-824
• 19 Hvatum M, Prydz H. Studies on tissue thromboplastin. Its splitting into two separate parts. Thromb Diath Haemorrh 1969; 21: 217-222
• 20 Prydz H, Allison AC. Tissue thromboplastin activity of isolated human monocytes. Thromb Haemostas 1978; 39: 582-591
• 21 Ewan VA, Cieplinski W, Hancock WW, Goldschneider I, Boyd AW, Rickies FR. Production and characterization of a monoclonal antibody (Al-3) that binds selectively to activated monocytes and inhibits monocyte procoagulant activity. J Immunol 1986; 136: 2408-2415
• 22 Bjorklid E, Giercksky E, Prydz H. An immunoradiometric assay for factor III. Br J Haematol 1978; 39: 445-458
• 23 Kuhlmann WD, Peschke P. Commercial polyclonal and monoclonal histostaining PAP kits. Immunoperoxidase reagents and performance characteristics in comparison with self-prepared immunoreagents. Histochemistry 1985; 82: 411-419
• 24 Fisher KL, Gorman CM, Vehar GA, O’Brien DP, Lawn RM. Cloning and expression of human tissue factor cDNA. Thromb Res 1987; 48: 89-99
• 25 Rao LV M, Rapaport SI. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood 1987; 69: 645-651